Joseph Slattery has been a member of our Board since 2017 and previously served as our lead independent director from March 2019 until March 31, 2020. Joe currently serves on the boards of directors of Omega Alpha SPAC, Morphic Therapeutic, Inc. and CVRx Inc., and he previously served as a director of Baxano Surgical, Inc., Exosome Diagnostics, Inc. and Micromet, Inc. He previously served as executive vice president and CFO of TransEnterix, Inc. (now Asensus Surgical, Inc.), as executive vice president and CFO at Baxano Surgical Inc., and as CFO and senior vice president of finance and information systems of Digene Corp. Joseph earned his bachelor’s degree in accountancy from Bentley University and is a certified public accountant.